Medical therapy of otitis externa and otitis media.
Medical regimens for the successful treatment of infectious otitis may vary widely depending on the degree of pathologic changes of the external ear canals, the status of the tympanic membranes, and the specific microorganisms involved. Chronic otitis media is especially problematic, because impaction of the bullae can be difficult to resolve and these cases often involve antibiotic-resistant bacterial organisms. In fact, the continuing emergence of resistant Pseudomonas spp and Staphylococcus spp will ensure that the medical therapy of otitis remains a dynamic art for the foreseeable future. This article considers the specific antimicrobial agents available for otic use, their potential toxicities, and guidelines for their use.
Morris
Daniel O
DO
Section of Dermatology and Allergy, Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, VHUP Room 2065, 3900 Delancey Street, University of Pennsylvania, Philadelphia, PA 19104, USA. domorris@vet.upenn.edu
D000208:Acute Disease; D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D002908:Chronic Disease; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D010032:Otitis Externa / Q000188:drug therapy / Q000662:veterinary*; D010033:Otitis Media / Q000188:drug therapy / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents